

N4 Pharma Plunges 40% As Covid-19 Antibody Delivery Study Disappoints


(Sharecast News) - N4 Pharma lost more than a third of its value after the company said its potential Covid-19 vaccine delivery method did not produce...


IN BRIEF: N4 Pharma Signs Technology Transfer & Manufacturing Contract


(Sharecast News) - Specialist pharmaceutical company N4 Pharma has appointed the API and nanomedicines business unit of Ardena as its contract develop...


N4 Pharma Shares Spike 30% On Successful Covid-19 Study


IN BRIEF: N4 Pharma's Nuvec Shows Promise In Oral Vaccine Delivery


UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work


(Sharecast News) - Pharmaceutical group N4 Pharma has completed the first phase of Covid-19 proof of concept work for Nuvec, the group's novel deliver...